國家衛生研究院 NHRI:Item 3990099045/4381
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 912877      線上人數 : 1164
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4381


    題名: Medical resource utilizations and economic burden in Chinese cancer patients with chemotherapy-induced anemia: A populational database study
    作者: Liu, CY;Liu, TW;Liu, JS;Hsiao, CF;Chen, LT
    貢獻者: Division of Biostatistics and Bioinformatics;National Institute of Cancer Research
    摘要: Objective: Most of published studies emphasized the medical cost of treating chemotherapy-induced anemia ( CIA) by using specific agents, for example, epoetin alpha, epoetin beta, darbepoetin a or combined with red blood cell transfusions, however, the investigation of the overall medical resources utilizations and economic burden of CIA is still limited. Besides, such studies which emphasized Chinese population still lack. The aim of this study is to investigate the medical resource utilization and the economic burden of Chinese cancer patients with CIA by using a populational representative claim database. Methods: The data for this study are from the 2000-2003 Population Health Insurance Research Database (PHIRD) in Taiwan. On the basis of issuing catastrophic illness cards in the enrollment data files, a total of 26,053 beneficiaries were identified from the PHIRD, who were newly diagnosed with these four cancers in 2001 and 2002 (2001: n=12,954; 2002: n=13099). A generalized linear model (GLM) was employed for analyzing the differences of medical resource utilization and economic burden between the anemic and non-anemic groups. Results: Analyses showed that the anemic patients were significantly more likely to have longer length of hospital stay than non-anemic patients (P < 0.05) across all these four cancers and in two study periods ( except women breast cancer in 2002/03). As regards the health care expenditures, the average one-year total medical cost was USD$ 8,982 (2001/02) and USD$ 8,990 (2002/03) for anemic patients among these four cancers, and USD$ 7,769 (2001/02) and USD$ 7713 (2002/03) for non-anemic patients (P<0.0001). As for ambulatory costs, anemic patients' was significantly higher than non-anemic patients' for lung cancer (in 2001/02), women breast cancer ( in 2001/02 and 2002/03) and the summarized data (in 2001/02). As for inpatient costs, anemic patients' was significantly higher than non-anemic patients' for gastric cancer (in 2002/03), colon and rectal cancer (in 2001/02 and 2002/03), lung cancer ( in 2001/02 and 2002/03), women breast cancer (in 2001/02) and the summarized data ( in 2001/02 and 2002/03). Conclusion: This study is the first study to demonstrate that cancer patients who receive chemotherapy and with anemia utilize more medical resources and have heavier economic burden among Chinese cancer patients. Although the Population Health Insurance Program in Taiwan was established to provide more low-burdened medical care for all cancer patients, further effort is still needed to reduce the economic burden for cancer patients who have specific complications.
    日期: 2008-12
    關聯: Chinese Journal of Cancer Research. 2008 Dec;20(4):307-315.
    Link to: http://dx.doi.org/10.1007/s11670-008-0307-6
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1000-9604&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000263257300013
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=57649224787
    顯示於類別:[陳立宗] 期刊論文
    [劉滄梧] 期刊論文
    [蕭金福] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000263257300013.pdf1047KbAdobe PDF280檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋